Kho, Changwon
Lee, Ahyoung
Jeong, Dongtak
Oh, Jae Gyun
Gorski, Przemek A.
Fish, Kenneth
Sanchez, Roberto
DeVita, Robert J.
Christensen, Geir
Dahl, Russell
Hajjar, Roger J.
Article History
Received: 2 July 2014
Accepted: 18 April 2015
First Online: 12 June 2015
Competing interests
: R.J.H. is the scientific cofounder of Celladon Corporation, which is developing AAV1.SERCA2a for the treatment of HF. All other authors declare no competing financial interests.